日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma

神经母细胞瘤中,跨空间域的早期进化分支易导致化疗期间的克隆替换。

Jenny Karlsson ,Hiroaki Yasui ,Adriana Mañas ,Natalie Andersson ,Karin Hansson ,Kristina Aaltonen ,Caroline Jansson ,Geoffroy Durand ,Naveen Ravi ,Michele Ferro ,Minjun Yang ,Subhayan Chattopadhyay ,Kajsa Paulsson ,Diana Spierings ,Floris Foijer ,Anders Valind ,Daniel Bexell ,David Gisselsson

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

乳腺癌相关 CD169+ 巨噬细胞具有广泛的免疫抑制功能,但可增强活化 B 细胞的抗体分泌

Frida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, Eva Källberg, Cajsa Andersen, Robert Grenthe, Cassandra Rosenqvist, Camilla Rydberg Millrud, Mika Wallgren, Hannah Viklund, Daniel Bexell, Martin E Johansson, Ingrid Hedenfalk, Catharina Hagerling, Karin Leandersson

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance

PDX 模型的临床相关治疗揭示了神经母细胞瘤化学耐药的模式

Adriana Mañas, Kristina Aaltonen, Natalie Andersson, Karin Hansson, Aleksandra Adamska, Alexandra Seger, Hiroaki Yasui, Hilda van den Bos, Katarzyna Radke, Javanshir Esfandyari, Madhura Satish Bhave, Jenny Karlsson, Diana Spierings, Floris Foijer, David Gisselsson, Daniel Bexell

Anti-tumor effects of rigosertib in high-risk neuroblastoma

rigosertib 在高危神经母细胞瘤中的抗肿瘤作用

Katarzyna Radke, Karin Hansson, Jonas Sjölund, Magdalena Wolska, Jenny Karlsson, Javanshir Esfandyari, Kristian Pietras, Kristina Aaltonen, David Gisselsson, Daniel Bexell

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

高危神经母细胞瘤临床前模型中 KSP 的治疗靶向性

Karin Hansson, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M Smith, Kristian Pietras, Sven Påhlman, Krister Wennerberg, David Gisselsson, Daniel Bexell

Integrative discovery of treatments for high-risk neuroblastoma

高危神经母细胞瘤治疗的综合发现

Elin Almstedt, Ramy Elgendy, Neda Hekmati, Emil Rosén, Caroline Wärn, Thale Kristin Olsen, Cecilia Dyberg, Milena Doroszko, Ida Larsson, Anders Sundström, Marie Arsenian Henriksson, Sven Påhlman, Daniel Bexell, Michael Vanlandewijck, Per Kogner, Rebecka Jörnsten, Cecilia Krona, Sven Nelander

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness

ETS 转录因子 ETV5 是神经母细胞瘤中活化 ALK 的靶点,可导致肿瘤侵袭性增强

Liselot M Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, Olivier De Wever, Daniel Bexell, Matthias Fischer, Bengt Hallberg, Johannes Schulte, Bram De Wilde, Kaat Durinck, Geertrui Dene

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma

发现表普利林作为治疗长春新碱耐药神经母细胞瘤的新药

Wondossen Sime, Mohamed Jemaà, Yasmin Abassi, Vito Alessandro Lasorsa, Julie Bonne Køhler, Karin Hansson, Daniel Bexell, Martin Michaelis, Jindrich Cinatl Jr, Daniel Strand, Mario Capasso, Ramin Massoumi

Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma

PIM/PI3K/mTOR 三重激酶抑制剂 IBL-302 对神经母细胞瘤的抗肿瘤作用

Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Apiricio, Cristian Garcia-Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer von Stedingk, Daniel Bexell

The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis

Iroquois 同源框蛋白 IRX3 和 IRX5 在 Wilms 肿瘤发展和人类肾脏发生中发挥着不同的作用

Linda Holmquist Mengelbier, Simon Lindell-Munther, Hiroaki Yasui, Caroline Jansson, Javanshir Esfandyari, Jenny Karlsson, Kimberly Lau, Chi-Chung Hui, Daniel Bexell, Sevan Hopyan, David Gisselsson